RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Common Sense should prevailLook at the company history. They have been advancing their diabetes program on a shoestring couple of million dollars a year for years. Funny how they have the best human data in the field and have advanced two other therapeutic programs. With the bought deal the company now has the funds to better compete with their American peers. They are hiring more staff to advance their programs faster and stock options are part of the package to bring in quality staff and is standard in this field. In fact, options align staff with investors interests. Voting against the option plan cuts off the company at the knees. Complaining about the company raising money and gaining institutional investors does the same. It’s surprising how posts here often make suggestions that actually hurt or stifle investor interests. Or is the purpose to stimulate unwitting investors to sell so others can accumulate stock…